Page last updated: 2024-10-26

etidronate and Precursor Cell Lymphoblastic Leukemia-Lymphoma

etidronate has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Precursor Cell Lymphoblastic Leukemia-Lymphoma: A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Döbert, N1
Martin, H1
Kranert, WT1
Menzel, C1
Klein, SA1
Mose, S1
Grünwald, F1

Other Studies

1 other study available for etidronate and Precursor Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Re-186 HEDP conditioning therapy in patients with advanced acute lymphoblastic leukemia before allogeneic bone marrow transplantation.
    Clinical nuclear medicine, 2003, Volume: 28, Issue:9

    Topics: Adult; Bone Marrow Transplantation; Etidronic Acid; Humans; Kidney; Male; Organometallic Compounds;

2003